Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2013

Jun 19, 2013

31046_dirs_2013-06-19_b96fb807-9ffe-4833-a3bf-9f901718c837.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-06-19

Reporting Person: Boulding Mark Elliott (Exec. VP and CLO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 42284 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $10.85 2023-05-15 Common Stock (20000) Direct
Stock Option (right to buy) $10.85 2023-05-15 Common Stock (100000) Direct
Stock Option (right to buy) $218.40 2022-01-10 Common Stock (191) Direct
Stock Option (right to buy) $490.80 2021-04-27 Common Stock (233) Direct
Stock Option (right to buy) $1149.60 2020-02-02 Common Stock (200) Direct
Stock Option (right to buy) $451.20 2019-05-15 Common Stock (233) Direct
Stock Option (right to buy) $735.60 2018-04-01 Common Stock (195) Direct
Stock Option (right to buy) $735.60 2018-01-25 Common Stock (166) Direct
Stock Option (right to buy) $626.40 2017-04-18 Common Stock (216) Direct
Stock Option (right to buy) $392.40 2016-03-01 Common Stock (101) Direct
Stock Option (right to buy) $226.80 2015-05-24 Common Stock (106) Direct
Stock Option (right to buy) $226.80 2014-11-05 Common Stock (602) Direct

Footnotes

F1: This option was granted on May 15, 2013 and vests over four years, subject to achievement of specified performance objectives, with 25% of the shares underlying the option vesting on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.

F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vesting on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.

F3: This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2013.

F4: This option was granted on April 27, 2011 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2012 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2012.

F5: This option was granted on February 2, 2010 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2011 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2011.

F6: Currently exercisable.